I think that people are realising that this stock is undervalued and seems guaranteed (dangerous words) to go up. It "should" be worth at least 30 million now, before the Hep A deal is done, and it seems like a given that the Hep A will be done, question is with whom.
What is scary is that sharp rises tend to see sharp falls following. Will this happen with SLT now? Given that it is being re-rerated, I hope not.
being re-rated
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)